Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant.
Reetakshi AroraColin N HaileTherese A KostenYan WuMuthu RamakrishnanLynn D HawkinsFrank M OrsonThomas R KostenPublished in: The American journal on addictions (2019)
Together, anti-MA vaccine showing a promising improvement in the efficacy of the vaccine that could be an effective candidate vaccine for methamphetamine use disorder (MUD). Furthermore, combinations of adjuvants may be a tool to design vaccines for MA dependence in humans. (Am J Addict 2019;XX:1-8).